semaglutide oral fda approval US accepts Novo Nordisk's application for Wegovy for weight loss Oral semaglutide (Rybelsus) is the

These targets remain appropriate for patients on GLP-1 therapy, though individual tolerance and titration may be necessary

While there is not yet an official timeline, Eli Lilly executives have said they plan to submit orforglipron for federal approval by the end of the year

Regardless of cause, if left unchecked, excess weight can contribute to chronic health conditions such as arthritis and other joint issues

Lifestyle factors play a role

In the placebo group, one patient withdrew voluntarily, two due to protocol noncompliance and one due to inappropriate handling of the study medication

Punitive damages are monetary awards that courts sometimes order defendants to pay as a form of punishment, not as compensation for the plaintiffs losses